John Peter Smith Hospital is a Level 1 Trauma Center, 573-bed county hospital located in Fort Worth, Texas that provides inpatient, outpatient and behavioral healthcare.

There are 573 beds in JPS Health Network.

During the past decade, JPS Health Network conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JPS Health Network" #1 sponsor was "CalciMedica, Inc." with 3 trials, followed by "NeuroRx, Inc." with 3 trials sponsored, "Atox Bio Ltd" with 2 trials sponsored, "Smith & Nephew, Inc." with 2 trials sponsored and "Zoll Medical Corporation" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JPS Health Network" #1 collaborator was "Target Health Inc." with 2 trials as a collaborator, "American Heart Association" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Brentwood Foundation" with 1 trials as a collaborator and "Cancer Prevention Research Institute of Texas" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "JPS Health Network" are "Bipolar Depression" (3 trials), "Heart Failure" (3 trials), "Pneumonia" (3 trials), "Necrotizing Fasciitis" (2 trials) and "Suicidal Ideation" (2 trials). Many other conditions were trialed in "JPS Health Network" in a lesser frequency.

Most popular intervention types in "JPS Health Network" are "Drug" (16 trials), "Device" (11 trials), "Procedure" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Auxora" (2 trials), "Lurasidone HCl" (2 trials), "NRX-101" (2 trials) and "AB103 0.5 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "JPS Health Network" are 33 trials for "All" genders.

Currently, there are NaN active trials in "JPS Health Network". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in JPS Health Network, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in JPS Health Network, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

JPS Health Network has several departments that took part in Clinical trials: "JPS Center for Cancer Care" - 5 trials